Active Ingredient History

  • Now
Edivoxetine is a drug which acts as a selective norepinephrine reuptake inhibitor and was under development by Eli Lilly for attention-deficit disorder (ADD) and as an antidepressant treatment. It was in phase III clinical trials, in 2012, for major depressive disorder, but failed to get approval.   Wikipedia

  • SMILES: COc1ccc(F)cc1C[C@@](O)(C2CCOCC2)[C@@H]3CNCCO3
  • Mol. Mass: 339.41
  • ALogP: 1.52
  • ChEMBL Molecule:
More Chemistry
alpha-((5-fluoro-2-methoxyphenyl)methyl)-alpha-(tetrahydro-2h-pyran-4-yl)-2-morpholinemethanol | edivoxetine | ly2216684 | ly 2216684 | ly-2216684


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue